HCA Healthcare Inc. ($HCA) Stock Forecast: Up 5.7% Today

What is HCA Healthcare Inc.?

HCA Healthcare Inc. (HCA) is a leading healthcare services provider, offering a wide range of medical services across its network of hospitals and outpatient centers. The company has recently reported strong quarterly earnings and positive guidance, leading to a bullish market movement.

Why is HCA Healthcare Inc. going up?

HCA stock is up 5.7% on Feb 12, 2026 14:36

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

HCA Price Chart

HCA Technical Analysis

HCA News

HCA Healthcare, Inc. $HCA Shares Sold by LSV Asset Management

LSV Asset Management decreased its stake in HCA Healthcare by 2.9% in Q3, selling 25,226 shares but still holding a significant position valued at $359.6 million. Concurrently, HCA's EVP Michael S. Cuffe sold 1,500 shares, reducing his ownership. The company reported strong quarterly earnings, beating expectations, and raised its quarterly dividend, while several analysts adjusted their ratings and price targets for HCA shares.

https://www.marketbeat.com/instant-alerts/filing-hca-healthcare-inc-hca-shares-sold-by-lsv-asset-management-2026-02-12/

Zacks Research Raises Earnings Estimates for HCA Healthcare

Zacks Research has increased its FY2026 EPS estimate for HCA Healthcare to $29.31 from $28.47, while maintaining a "Hold" rating. This upgrade follows HCA's stronger-than-expected Q4 performance, with EPS of $8.01 against an expected $7.37, and the company's positive FY2026 guidance of $29.10–$31.50 EPS. Analysts generally hold a "Moderate Buy" consensus for HCA, with a price target around $523.

https://www.marketbeat.com/instant-alerts/zacks-research-raises-earnings-estimates-for-hca-healthcare-2026-02-12/

HCA Healthcare Inc (HCA) Shares Up 4.7% on Feb 11

HCA Healthcare Inc (HCA) shares rose 4.70% on February 11, reaching an intraday high of $525.64. This places the stock just below its 52-week high, with significant gains from its 52-week low. Analysts have an average target price of $528.46, indicating an "Outperform" consensus, although GuruFocus's GF Value suggests a potential downside from the current price.

https://www.gurufocus.com/news/8607103/hca-healthcare-inc-hca-shares-up-47-on-feb-11?mobile=true

HCA Healthcare (NYSE:HCA) Reaches New 1-Year High - Here's Why

HCA Healthcare (NYSE:HCA) reached a new 52-week high of $529.53, driven by strong quarterly earnings that surpassed analyst expectations, positive FY2026 guidance, and upward revisions of EPS forecasts. The company's strategic expansion into outpatient services and an increased quarterly dividend further bolstered investor confidence, despite some minor negative sentiment from a trimmed Q1 2026 EPS estimate and an insider share sale. Analyst ratings generally suggest a "Moderate Buy" with an average target price of $523.27.

https://www.marketbeat.com/instant-alerts/hca-healthcare-nysehca-reaches-new-1-year-high-heres-why-2026-02-11/

Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day

Universal Health Services Inc. Cl B (UHS) stock saw a strong performance, rising 2.21% to $151.71, outpacing competitors. The stock also traded above its 50-day and 200-day moving averages, indicating a positive trend. Volume increased significantly compared to its 50-day average.

https://www.msn.com/en-us/money/topstocks/universal-health-services-inc-cl-b-stock-outperforms-competitors-on-strong-trading-day/ar-AA1W9Orw?ocid=finance-verthp-feeds

Trending Today

Lemonda Inc. ($LMND) Stock Forecast: Down 7.5% Today

Align Technology Inc. ($ALGN) Stock Forecast: Up 5.2% Today

CDW Corporation ($CDW) Stock Forecast: Up 6.4% Today

Verisk Analytics Inc. ($VRSK) Stock Forecast: Up 5.3% Today

Vulcan Materials Company (Holding Company) ($VMC) Stock Forecast: Up 5.1% Today

Academy Sports and Outdoors, Inc. ($ASO) Stock Forecast: Up 5.2% Today

WillScot Mobile Mini Holdings Corp. ($WSC) Stock Forecast: Up 5.0% Today

Whirlpool Corporation ($WHR) Stock Forecast: Down 6.6% Today

CRISPR Therapeutics AG ($CRSP) Stock Forecast: Up 6.3% Today

Digital Ocean Holdings ($DOCN) Stock Forecast: Up 7.2% Today

HCA Healthcare Inc. Price History

11.01.2026 - HCA Stock was up 5.0%

• The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
• HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
• The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
• HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

05.00.2026 - HCA Stock was up 1.7%

• HCA Healthcare's stock rallied steadily due to strong fundamentals, consistent guidance, and a focus on returning cash to shareholders, attracting investor attention away from tech giants.
• The reduction in stake by Gateway Investment Advisers LLC and an EVP could indicate profit-taking after strong Q3 earnings and price target upgrades, contributing to the stock's positive momentum.
• The adoption of advanced robotics for orthopedic surgeries at Marion County HCA Hospitals showcases HCA's commitment to innovation and improving patient outcomes, potentially boosting investor confidence in the company's growth prospects.
• Despite a lower P/E ratio compared to the broader market, investors remain cautious about HCA Healthcare's future earnings volatility or potential threats, reflecting a sense of uncertainty despite the positive market outlook.

09.05.2025 - HCA Stock was down 0.2%

• The bearish movement in HCA stock today could be attributed to profit-taking by investors after a prolonged period of growth.
• The long-term investment potential of HCA may have led some investors to reassess their short-term positions, contributing to the bearish movement.
• Market volatility and broader economic factors may have also played a role in the downward movement of HCA stock today.

16.05.2025 - HCA Stock was down 4.1%

• Despite a bullish stance from investors with significant capital, HCA Healthcare experienced a strong bearish movement in the stock market today.
• The discrepancy between the bullish options trading activity and the bearish stock movement could indicate a divergence in market sentiment and actual performance of the company.
• It is possible that external factors, such as broader market conditions or specific company-related news not mentioned in recent updates, contributed to the bearish movement in HCA's stock price today.

27.00.2026 - HCA Stock was up 6.5%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
• Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
• Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
• Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

11.01.2026 - HCA Stock was up 6.6%

• Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
• The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
• The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

12.01.2026 - HCA Stock was up 5.7%

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

22.06.2025 - HCA Stock was down 0.6%

• The bearish movement in HCA stock today could be attributed to the lack of optimistic expectations for its upcoming Q2 earnings:
• Analysts are cautious about the potential for an earnings beat, as the company may not possess the right combination of key ingredients.
• Investors might be adjusting their positions in anticipation of underwhelming performance in key metrics for the quarter ended June 2025.
• The market sentiment seems to be influenced by the uncertainty surrounding HCA Healthcare's earnings growth prospects, leading to a downward pressure on the stock price.

24.09.2025 - HCA Stock was up 2.4%

• HCA Healthcare (HCA) exceeded expectations in Q3 earnings and revenues, reflecting a strong performance during the last quarter.
• Analysts adjusted their forecasts for HCA Healthcare before the earnings announcement, expecting a rise in quarterly earnings per share.
• With a track record of outperforming the market over the past decade, HCA Healthcare has consistently delivered returns to its investors.
• Despite concerns about rising costs affecting Q3 earnings, the company's robust revenue growth has fueled a bullish trend in its stock.

24.10.2025 - HCA Stock was down 1.9%

• The bearish movement in HCA stock today could be due to concerns about increased competition and potential market share loss following Teladoc's aggressive acquisition strategy in the healthcare industry.
• Investors might be worried that Teladoc's expanding global footprint and growth across key segments could pose a threat to HCA's market position and profitability.
• The market might be reacting to the perceived long-term impact of Teladoc's strategic moves on HCA's business prospects, leading to a sell-off of HCA shares in today's trading session.